ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 671172 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 671172; 2) Community: the network communities that were significantly associated with the response to NSC 671172; 3) Molecule: the relationships between components within communities and NSC 671172; 4) MDR: the compounds that were significantly associated with the NSC 671172.

NSC Compound Enrichment Correlation
NSC 748904 [(20S)-20-(N,N-dimethylamino)-5a-preg-3a-aminal], N-formylchonemorphine 0.0186186224062459 0.25950331
NSC 93135 OXYACANTHINE 0.0186186224062459 0.38153526
NSC 673190 Null 0.0212053315848709 0.66448019
NSC 677942 L-Glutamamide, N(2)-[4-[[(2,4-diamino-6-pteridinyl)methyl](methyl)amino]benzoyl]-N(1),N(5)-didecyl- 0.0212053315848709 0.44529572
NSC 681684 2-Trifluoroethoxy-6-oxoestra-1,3,5(10)-trien-3,17.beta.-diol 0.0212053315848709 0.63906278
NSC 686556 Benzo[g]quinoline-5,10-dione, 4-[2-(dimethylamino) ethenyl]- 0.0212053315848709 0.46578358
NSC 706031 Null 0.0212053315848709 0.26241659
NSC 685034 Null 0.021205331584871 0.11115534
NSC 736567 Null 0.021205331584871 0.28894207
NSC 174121 Methotrexate Derivative 0.0212053315848711 0.36501865
Total:53  Current:22    [First] [Prev] [Next] [Last]